TVRD- Tvardi Therapeutics, Inc.

Name: Tvardi Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Tvardi Therapeutics, Inc. (TVRD) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. TVRD is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Alibhai Imran Nizamudin	47.5K	$198.6K	-
Other	Kauh John Saewook M.D.	17.5K	$73.2K	-
CFO	Conn Avi Daniel	17.5K	$73.2K	-
Other	O'Brien Stephen Paul	4.0K	$16.7K	-
10%	Tweardy Samuel David	0	-	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 4, 2023	Goncalves Joana90	Chief Medical Officer	Sell	2,481	$4.91	$12,181.71	-4.2%	-38.8%	-80.9%
Apr 4, 2023	Menzaghi Frederique Ph.d.85	Chief Scientific Off,Svp-r&D	Sell	2,733	$4.91	$13,419.03	-1.7%	-38.8%	-80.9%
Mar 3, 2023	Posner Christopher80	President And CEO	Sell	5,987	$9.71	$58,133.77	-3.3%	-69.9%	-90.8%
Mar 3, 2023	Menzaghi Frederique Ph.d.85	Chief Scientific Off,Svp-r&D	Sell	6,802	$9.71	$66,047.42	-4.1%	-69.9%	-90.8%
Mar 3, 2023	Terrillion Scott90	Sec'y; Chief Compliance &G.c.	Sell	6,256	$9.71	$60,745.76	-6.3%	-69.9%	-90.8%
Mar 3, 2023	Goncalves Joana90	Chief Medical Officer	Sell	6,221	$9.71	$60,405.91	-9.6%	-69.9%	-90.8%
Feb 16, 2023	Goncalves Joana90	Chief Medical Officer	Sell	2,265	$10.20	$23,103.00	-3.4%	-59.7%	-94.0%
Feb 8, 2023	Terrillion Scott90	Sec'y; Chief Compliance &G.c.	Sell	7,770	$0.53	$4,118.10	-7.6%	-64.2%	-95.5%
Feb 8, 2023	Maynard Ryan D75	Chief Financial Officer	Sell	5,488	$0.53	$2,908.64	-40.7%	-64.2%	-95.5%
Feb 8, 2023	Goncalves Joana90	Chief Medical Officer	Sell	7,770	$0.53	$4,118.10	-11.6%	-64.2%	-95.5%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC